— Know what they know.
Not Investment Advice

HSKA NASDAQ

Heska Corporation
1W: +0.1% 1M: +2.5% 3M: +43.7% 1Y: +27.4% 3Y: +32.0% 5Y: +12.3%
$119.99
Last traded 2023-06-12 — delisted
NASDAQ · Healthcare · Medical - Devices · $1.3B mcap · 10M float · 3.45% daily turnover

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$257M +1.4% ▲
5Y CAGR: +14.7%
Gross Profit
$111M +5.1% ▲
5Y CAGR: +13.8%
Operating Income
-$20M -1944.1% ▼
Net Income
-$18M -14057.6% ▼
EPS (Diluted)
$-1.78 -13584.8% ▼
EBITDA
-$20M -1944.1% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
Revenue$127M$123M$197M$254M$257M
YoY Growth-1.5%-3.8%+60.9%+28.6%+1.4%
Cost of Revenue$71M$68M$116M$148M$146M
Gross Profit$57M$54M$81M$106M$111M
Gross Margin44.4%44.4%41.2%41.7%43.2%
R&D Expenses$3M$8M$9M$7M$20M
SG&A Expenses$50M$46M$81M$100M$112M
Operating Expenses$53M$54M$89M$107M$131M
Operating Income$4M-$5M-$8M-$993K-$20M
Operating Margin2.9%-3.7%-4.2%-0.4%-7.9%
Interest Expense$310K$3M$6M$4M$2M
Income Before Tax$4M-$3M-$14M-$3M-$22M
Tax Expense-$2M-$1M$239K-$4M-$3M
Net Income$6M-$1M-$14M$132K-$18M
Net Margin4.6%-0.9%-7.1%0.1%-7.2%
EPS (Diluted)$0.74$-0.15$-1.62$0.01$-1.78
EBITDA$4M$327K$4M$14M-$20M
Shares Outstanding8M7M9M10M10M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms